Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-16 | Future report Set alerts | |
Q2 2022 | 2022-08-18 | 0.00 | 0.00 |
Q1 2022 | 2022-05-18 | 0.00 | 0.00 |
Q4 2021 | 2022-03-02 | 1.13 | 1.13 |
Q3 2021 | 2021-11-17 | 0.00 | 0.00 |
Q2 2021 | 2021-08-19 | 0.00 | 0.00 |
Q1 2021 | 2021-05-20 | 0.26 | 0.26 |
Q4 2020 | 2021-03-03 | 0.25 | 0.25 |
Q3 2020 | 2020-11-18 | 0.00 | 0.00 |
Q2 2020 | 2020-08-19 | 0.00 | 0.19 |
2016-07-13 | Downgrade | Citigroup Inc. | Neutral to Sell | |
2016-07-05 | Reiterated Rating | Bank of America Corp. | Hold | $28.00 |
2016-06-06 | Upgrade | Scotiabank | Sector Perform to Outperform | |
2016-01-21 | Lower Price Target | HSBC | Hold | $19.00 to $17.50 |
2015-12-18 | Upgrade | Bank of America | Neutral to Buy | |
2015-12-18 | Upgrade | Bank of America Corp. | Neutral to Buy | |
2015-12-08 | Upgrade | Santander | Underperform to Hold | $18.71 |
2015-11-17 | Downgrade | HSBC | Buy to Hold | $18.50 to $19.00 |
2015-10-19 | Lower Price Target | Scotiabank | $24.00 to $22.00 | |
2015-09-30 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $28.00 to $20.00 |
2015-09-11 | Boost Price Target | Scotiabank | $20.00 to $24.00 | |
2015-08-28 | Reiterated Rating | Scotiabank | Sector Perform | $20.00 |
2015-08-28 | Initiated Coverage | Howard Weil | Sector Perform | $27.00 to $20.00 |
2015-07-08 | Lower Price Target | HSBC | Hold to Buy | $23.50 to $18.50 |
2015-07-02 | Upgrade | HSBC | Hold to Buy | $23.50 to $18.50 |
2015-04-02 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $28.00 |
2015-03-05 | Lower Price Target | Miller Tabak | Buy | $33.00 to $30.00 |
2014-09-16 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $30.00 to $31.00 |
2014-07-18 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $37.00 to $30.00 |
2014-05-14 | Downgrade | Credit Suisse | Neutral to Underperform | $34.00 to $27.00 |
2014-04-28 | Downgrade | HSBC | Neutral to Underweight | |
2014-04-11 | Upgrade | Bank of America | Underperform to Neutral | $25.00 to $34.00 |
2014-03-05 | Reiterated Rating | Morgan Stanley | Equal Weight | $30.00 |
2013-11-04 | Upgrade | HSBC | Underweight to Neutral | $26.00 to $31.00 |
2013-03-07 | Downgrade | Miller Tabak | Buy to Hold | $60 |
2010-02-26 | Upgrade | JP Morgan | Underweight to Neutral | |
2009-01-07 | Downgrade | JP Morgan | Overweight to Neutral |
2016-07-13 | Downgrade | Citigroup Inc. | Neutral to Sell | |
2016-07-05 | Reiterated Rating | Bank of America Corp. | Hold | $28.00 |
2016-06-06 | Upgrade | Scotiabank | Sector Perform to Outperform | |
2016-01-21 | Lower Price Target | HSBC | Hold | $19.00 to $17.50 |
2015-12-18 | Upgrade | Bank of America | Neutral to Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SQM 216 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Capital International Investors | 7.07M |
BlackRock Inc. | 3.84M |
Mirae Asset Global Investments Co., Ltd. | 2.88M |
FMR LLC | 2.67M |
ALLIANCEBERNSTEIN L.P. | 1.50M |
STATE STREET CORP | 1.43M |
Global X Management CO LLC | 1.39M |
RENAISSANCE TECHNOLOGIES LLC | 1.25M |
ROBECOSAM AG | 1.23M |
CITADEL ADVISORS LLC | 1.15M |
EARNEST PARTNERS LLC | 1.15M |
MACQUARIE GROUP LTD | 1.11M |
Marshall Wace North America, L.P. | 1.03M |
MORGAN STANLEY | 0.99M |
GOLDMAN SACHS GROUP INC | 0.93M |